Connection

John Cavanagh to Humans

This is a "connection" page, showing publications John Cavanagh has written about Humans.
Connection Strength

0.055
  1. Evaluation of a 2-aminoimidazole variant as adjuvant treatment for dermal bacterial infections. Drug Des Devel Ther. 2017; 11:153-162.
    View in: PubMed
    Score: 0.021
  2. Evaluation of the toxicity of 2-aminoimidazole antibiofilm agents using both cellular and model organism systems. Drug Chem Toxicol. 2012 Jul; 35(3):310-5.
    View in: PubMed
    Score: 0.015
  3. Augmenting anti-cancer natural products with a small molecule adjuvant. Mar Drugs. 2014 Dec 26; 13(1):65-75.
    View in: PubMed
    Score: 0.005
  4. Small-molecule suppression of ?-lactam resistance in multidrug-resistant gram-negative pathogens. J Med Chem. 2014 Sep 11; 57(17):7450-8.
    View in: PubMed
    Score: 0.005
  5. Binding site on human immunoglobulin G for the affinity ligand HWRGWV. J Mol Recognit. 2010 May-Jun; 23(3):271-82.
    View in: PubMed
    Score: 0.003
  6. Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob Agents Chemother. 2010 May; 54(5):2112-8.
    View in: PubMed
    Score: 0.003
  7. Targeting RNA with cysteine-constrained peptides. Bioorg Med Chem Lett. 2008 Jan 15; 18(2):565-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.